Summary
Thermo Fisher Scientific Inc. (TMO) filed an 8-K on July 26, 2023, to report its financial results for the fiscal quarter ended July 1, 2023. The key information for investors is contained within the press release furnished as Exhibit 99.1 to this filing, which provides details on the company's performance and financial condition for the period. While the 8-K itself is a procedural document notifying the market of the earnings release, investors should refer to the attached press release for specifics on revenue, earnings per share (EPS), segment performance, and forward-looking guidance. This filing serves as the official notification of these results, making the press release the primary source for detailed financial analysis.
Key Highlights
- 1Thermo Fisher Scientific (TMO) announced its financial results for the fiscal quarter ended July 1, 2023.
- 2The official announcement was made via a press release furnished as Exhibit 99.1 to the 8-K filing.
- 3Investors should consult the press release for detailed financial performance, including revenue, EPS, and segment data.
- 4The 8-K filing acts as notification of the earnings release, with the press release containing the substantive financial information.
- 5This filing does not alter the 'filed' status of the information for Section 18 of the Exchange Act unless specifically referenced in other filings.